We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sapience Therapeutics announced today that it has entered into a Collaboration Agreement with the National Cancer Institute of the National Institutes of Health to investigate the activity of its lead clinical program